913753137
Conference Coverage

Advertise on podcast: Conference Coverage

Rating
★★★★★
5
from
1 reviews
This podcast has
376 episodes
Language
English
Publisher
ReachMD
Explicit
No
Date created
2014/08/28
Latest episode
2026/11/06
Average duration
6 min.
Release period
3 days

Description

ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.

Unlock Conference Coverage podcast Email contact info,
Listeners & Audience details

Email contact information

Direct podcast contact details

Listeners

Audience numbers & engagement insights

Audience details

Podcast Insights

Social media

Check Conference Coverage social media presence


Podcast episodes

Check latest episodes from Conference Coverage podcast


Metabolic Rewiring in DKD: The Role of Tubular Cells
2026/11/06
Guest: Kumar Sharma, MD, FAHA, FASN How does altered glucose metabolism contribute to kidney damage in patients with diabetes? Join Dr. Kumar Sharma, Chief of the Division of Nephrology and Vice Chair for Research in the Department of Medicine at UT Health San Antonio, as he explores the metabolic shift from fatty acid oxidation to glycolysis in proximal tubular cells, examining how excess glucose drives lactate production and disrupts mitochondrial function. Learn how emerging findings from patient kidney biopsies are advancing our understanding of metabolic dysfunction in diabetic kidney disease (DKD).
Exploring Metabolic Biomarkers for Earlier Detection and Treatment of DKD
2026/11/06
Guest: Kumar Sharma, MD, FAHA, FASN What if we could identify diabetic kidney disease (DKD) before traditional markers reveal kidney damage? Dr. Kumar Sharma joins us to explore how emerging blood and urine biomarkers may help identify these underlying changes, improve disease staging, and guide future therapeutic strategies that build on the kidney-protective benefits of SGLT2 inhibitors. He's the Chief of the Division of Nephrology and Vice Chair for Research in the Department of Medicine at UT Health San Antonio.
Exploring Drivers of DKD: Metabolic Rewiring and Mitochondrial Dysfunction
2026/11/06
Guest: Kumar Sharma, MD, FAHA, FASN Metabolic changes in the diabetic kidney can set off a cascade of cellular dysfunction, inflammation, and fibrosis that contributes to kidney damage. Join Dr. Kumar Sharma, Chief of the Division of Nephrology and Vice Chair for Research in the Department of Medicine at UT Health San Antonio, as he explains how metabolic rewiring, mitochondrial dysfunction, and excess adenine production contribute to the progression of diabetic kidney disease (DKD).
Understanding the Burden of Mucus Plugging in Patients with COPD
2026/11/06
Guest: Emily Wan, MD, MPH Mucus plugging is increasingly recognized as an important radiographic biomarker in patients with COPD, but what does its presence mean for clinical outcomes? Joining us to share insights from her presentation at the 2026 GOLD International COPD Conference is Dr. Emily Wan. She discusses the high prevalence of CT-detected mucus plugs, their distinction from symptomatic chronic bronchitis, and their associations with lung function decline, acute exacerbations, and increased all-cause mortality. Dr. Wan is the Section Chief of Pulmonary and Critical Care at the Minneapolis VA Health Care System and an Associate Professor of Medicine at the University of Minnesota.
A Patient-Centered Approach to Obesity Management
2026/11/03
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Ted Kyle Effective obesity care starts with recognizing the complexity of the condition and the impacts of weight bias and stigma on patient care. Joining Dr. Peter Buch to discuss the evolving role of GLP-1–based therapies and explore how shared decision-making can help clinicians engage patients as active partners in long-term obesity care is Ted Kyle. He's the Founder of ConscienHealth, Policy and Advocacy Advisor to the Obesity Society, and Past Chair of the Obesity Action Coalition.
Treating Obesity Today: GLP-1s, Surgery, and Beyond
2026/11/02
Guest: Devika Umashanker, MD Today, obesity treatment often combines medical and surgical strategies rather than following a strict step-by-step approach. GLP-1 therapies, older medications, and procedures like sleeve gastrectomy and gastric bypass all have a place in an individualized, patient-centered plan. Joining Dr. Peter Buch to discuss how we can integrate these approaches into obesity care is Dr. Devika Umashanker, Program Director of the Obesity Medicine Fellowship at Hartford HealthCare and an Associate Professor of Internal Medicine at the Frank H. Netter MD School of Medicine at Quinnipiac University.
Managing MASLD in Patients with Obesity
2026/11/02
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: David Tendler, MD Obesity is one of the biggest drivers of metabolic dysfunction-associated steatotic liver disease (MASLD), and the two conditions often need to be managed together. To get patients the results they need, clinicians must know how to screen effectively, rule out other liver conditions, and match treatment to disease stage. On this episode of GI Insights, Dr. Peter Buch talks with Dr. David Tendler about how to approach these decisions in everyday practice. Dr. Tendler is part of the clinical faculty at the Duke University Department of Medicine in Durham, North Carolina.
Personalizing Nutrition and Exercise Alongside GLP-1 Receptor Agonist Therapy
2026/11/02
Guest: Laura Chiavaroli, PhD As GLP-1 receptor agonists reduce appetite and food intake, nutrition and exercise counseling can help patients navigate potential gastrointestinal effects and nutrient shortfalls while establishing sustainable habits. Learn more as Dr. Laura Chiavaroli discusses how we can individualize dietary guidance and incorporate aerobic and resistance training based on patients’ preferences, access, and lifestyle. She's an Assistant Professor in the Department of Nutritional Sciences at the University of Toronto and an affiliate scientist at the Li Ka Shing Knowledge Institute at St. Michael's Hospital.
The Emerging Role of Triple Agonists in Obesity Management
2026/11/02
Guest: Javier Morales, MD, FACP, FACE The role of triple agonist therapies in obesity and type 2 diabetes management is evolving. Hear from Dr. Javier Morales as he explains how these therapies work and what these advances may mean for individualized treatment strategies. Dr. Morales is an Associate Clinical Professor of Medicine at the Barbara and Donald Zucker School of Medicine at Hofstra University and Northwell.
Closing Gaps in Atopic Dermatitis Treatment Across the Lifespan
2026/10/14
Guest: Andrew Mastro, MS, PA-C Despite advances in targeted topical therapies for atopic dermatitis, significant gaps remain in treatment access and options for patients at both ends of the age spectrum. Join Andrew Mastro, physician assistant at the Illinois Dermatology Institute and DeNova Research in Chicago, as he explores the challenges of treating infants and older adults, barriers to accessing newer therapies, and opportunities to improve patient outcomes across all age groups.
The Burden of Itch in Pediatric Atopic Dermatitis
2026/10/14
Guest: Mariam Iqneibi, MD For kids with atopic dermatitis, the itch-scratch cycle can perpetuate inflammation, damage the skin barrier, and significantly impact quality of life. Join Dr. Mariam Iqneibi, pediatric dermatologist at Cincinnati Children's Hospital and Assistant Professor of Dermatology at the University of Cincinnati College of Medicine, as she explores the mechanisms driving the itch-scratch cycle, the unique challenges of recognizing itch in infants, and practical strategies to help children and their families manage symptoms and minimize skin damage.
Breaking the Itch-Scratch Cycle in Pediatric Atopic Dermatitis
2026/10/14
Guest: Mariam Iqneibi, MD Persistent itching in children with atopic dermatitis can disrupt sleep, impair quality of life, and contribute to recurring flares. Join Dr. Mariam Iqneibi as she discusses practical strategies for breaking the itch-scratch cycle through effective inflammation control, proactive maintenance therapy, and gentle skincare. She's a pediatric dermatologist at Cincinnati Children's Hospital and an Assistant Professor of Dermatology at the University of Cincinnati College of Medicine.
Setting Expectations for Topical JAK Inhibitor Therapy in Atopic Dermatitis
2026/10/14
Guest: Andrew Mastro, MS, PA-C In atopic dermatitis, the timing of itch relief and visible skin improvement can make all the difference in how patients perceive their response to topical JAK inhibitor therapy. Andrew Mastro, physician assistant at the Illinois Dermatology Institute and DeNova Research in Chicago, shares his approach to translating clinical trial data into practical counseling strategies, setting meaningful treatment milestones, and timing follow-up visits to capture early wins and address emerging challenges.
Addressing Cardiovascular Risk in Prediabetes: Why Earlier Action Matters
2026/10/07
Guest: John W. Ostrominski, MD, MPH Prediabetes may signal more than the future development of diabetes; it can also provide an opportunity to identify and address cardiovascular risk earlier. Here to recap his presentation at the 2026 European Association for the Study of Diabetes Annual Meeting is Dr. John Ostrominski, preventive cardiologist and obesity medicine specialist at Brigham and Women's Hospital and Harvard Medical School. Dr. Ostrominski explains how cardiovascular risk assessment can inform individualized prevention strategies and why risk-reduction efforts should not wait until diabetes develops.
Exploring Sub-Ablative Radiation to Modulate Immunity in Mesothelioma
2026/10/05
Guest: John Cho, MD, PhD, FRCPC Could lower doses of radiation help optimize immune response in mesothelioma? Dr. John Cho joins us to explain how tailoring radiation to a tumor’s inflammatory and immunogenic characteristics could help modulate antitumor immunity while reducing the potential for fibrosis and treatment-related toxicity. Dr. Cho is a radiation oncologist at the Princess Margaret Cancer Centre and an Associate Professor in the Department of Radiation Oncology at the University of Toronto, and he spoke about this topic at the 2026 World Conference on Lung Cancer.

Podcast reviews

Read Conference Coverage podcast reviews


5 out of 5
1 reviews

Podcast sponsorship advertising

Start advertising on Conference Coverage relevant audience podcasts


What do you want to promote?